Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,585.00
Bid: 2,580.00
Ask: 2,585.00
Change: 5.00 (0.19%)
Spread: 5.00 (0.194%)
Open: 2,630.00
High: 2,630.00
Low: 2,580.00
Prev. Close: 2,580.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

6 Nov 2019 07:00

RNS Number : 3803S
Morgan Sindall Group PLC
06 November 2019
 

 

6 November 2019

 

Morgan Sindall Group plc

 

Trading Update

 

 

Morgan Sindall Group plc ("the Group") today provides an update on current trading and the outlook for the 2019 financial year.

Group performance and outlook

Trading has continued to be strong and the Group is now on track to deliver a full year performance which is slightly above the Board's previous expectations which were set at the time of the half year results on 7 August 2019.

Additionally, the average daily net cash for the full year is expected to be in excess of £100m, ahead of previous guidance.

Divisional highlights

The focus in Construction & Infrastructure remains on operational delivery, contract selectivity and risk management and its full year performance is expected to show further margin improvement over last year.

Market conditions for Fit Out have remained broadly stable over recent months and based on its visible workload, a strong performance in the second half of the year is expected.

The improved performance by Property Servicesdelivered in the first half of the year has continued and it is expected that its operating margin for the year will be well in excess of 3%.

Partnership Housing is progressing well, with the benefit of the ongoing operational improvements driving the expected growth in margin and profit for the full year.

 

In Urban Regeneration, progress on the various schemes within its development portfolio has been as expected, while Investments is on track to deliver a result for the year broadly similar to last year's.

Group secured workload

The total secured workload for the Group as at 30 September 2019 was £7.3bn, up 10% from the year end position (down 2% from the half year). This comprised the secured order book of £4.1bn, up 15% from the year end (down 3% from the half year) and the regeneration & development pipeline of £3.2bn, which was up 4% from the year end (down 2% from the half year).

Balance sheet

The Group's cash position remains strong and the average daily net cash from the start of the year to 31 October was £109m. Based upon this and current forecasts to the year end, the average daily net cash for the year is expected to be in excess of £100m (FY 2018: £99m).

John Morgan, Chief Executive, said:

"We continue to make good progress, with positive momentum across the Group's operations. Consequently, we now expect to deliver a full year performance slightly above the Board's previous expectations. Our strong balance sheet continues to be a significant differentiator and enables us to make the right long-term decisions for the business which position us well for continued sustainable growth."

 

This announcement contains inside information. The person responsible for the release of this announcement on behalf of Morgan Sindall Group plc is Steve Crummett, Group Finance Director.

 

ENDS

 

Morgan Sindall Group

 

Morgan Sindall Group plc is a leading UK construction and regeneration group with revenue of c£3bn, employing around 6,600 employees and operating in the public, regulated and private sectors. It operates through six divisions of Construction & Infrastructure, Fit Out, Property Services, Partnership Housing, Urban Regeneration and Investments.

 

ENQUIRIES:

 

Morgan Sindall Group plc Tel: 020 7307 9200

 

John Morgan, Chief Executive

Steve Crummett, Finance Director

 

Instinctif Partners Tel: 020 7457 2020

 

Matthew Smallwood

James Gray

Rosie Driscoll

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTCKPDDOBDDADK
Date   Source Headline
31st Oct 20132:18 pmRNSTotal Voting Rights
9th Oct 20134:41 pmRNSHolding(s) in Company
30th Sep 20134:48 pmRNSTotal Voting Rights
27th Sep 20131:22 pmRNSDirector/PDMR Shareholding
25th Sep 20135:01 pmRNSHolding(s) in Company
17th Sep 201310:06 amRNSHolding(s) in Company
30th Aug 20133:51 pmRNSTotal Voting Rights
13th Aug 20134:41 pmRNSHolding(s) in Company
13th Aug 201312:04 pmRNS£100m South Shields Regeneration Project
12th Aug 201311:47 amRNSNotifications of Major Interests in Shares
9th Aug 20131:11 pmRNSDirector/PDMR Shareholding
9th Aug 201312:00 pmRNSHolding(s) in Company
5th Aug 20137:00 amRNSHalf Yearly Report
31st Jul 20133:08 pmRNSTotal Voting Rights
11th Jul 20137:00 amRNS£269m Woolwich Redevelopment Programme Award
2nd Jul 20139:23 amRNSDirector Declaration
28th Jun 20132:45 pmRNSTotal Voting Rights
28th Jun 20137:19 amRNSDisposal of PFI interest
26th Jun 20134:17 pmRNSHolding(s) in Company
11th Jun 201310:30 amRNSHolding(s) in Company
31st May 201311:45 amRNSTotal Voting Rights
30th May 20138:11 amRNSBlocklisting Interim Review
24th May 20139:30 amRNSHolding(s) in Company
9th May 20131:53 pmRNSResult of AGM
9th May 20137:00 amRNSAGM and Q1 Interim Management Statement
7th May 20139:00 amRNSMuse Developments appointed preferred bidder
30th Apr 20131:53 pmRNSTotal Voting Rights
16th Apr 20137:00 amRNSLovell signs £63.3m Dagenham homes scheme
8th Apr 201310:12 amRNSHolding(s) in Company
2nd Apr 20139:45 amRNSHolding(s) in Company
28th Mar 20135:22 pmRNSHolding(s) in Company
28th Mar 20133:04 pmRNSTotal Voting Rights
26th Mar 20133:36 pmRNSAnnual Financial Report
20th Mar 20135:36 pmRNSDirector/PDMR Shareholding
15th Mar 20133:39 pmRNSHolding(s) in Company
13th Mar 20135:18 pmRNSHolding(s) in Company
1st Mar 201311:17 amRNSHolding(s) in Company
28th Feb 20133:59 pmRNSTotal Voting Rights
27th Feb 20135:21 pmRNSDirector/PDMR Shareholding
27th Feb 20132:56 pmRNSDirector/PDMR Shareholding
25th Feb 20137:00 amRNSBoard Changes
19th Feb 20137:00 amRNSPreliminary Results
8th Feb 201312:54 pmRNSHolding(s) in Company
8th Feb 201312:52 pmRNSHolding(s) in Company
31st Jan 20135:01 pmRNSTotal Voting Rights
10th Jan 20137:00 amRNSAppointment of Steve Crummett as Finance Director
31st Dec 20128:00 amRNSTotal Voting Rights
18th Dec 20127:00 amRNSPre-Close Statement
11th Dec 20124:43 pmRNSBlocklisting Interim Review
10th Dec 20122:22 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.